Olanzapine in Gilles de la Tourette syndrome: Beyond tics

Acta Neurologica Belgica

Volumn 105, Issue 4, 2005, Pages 206-211

  Van den Eynde, Frederique ^a   Naudts, K H ^b   De Saedeleer, S ^a   van Heeringen, C ^a   Audenaert, K ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antipsychotics; Gilles de la Tourette syndrome; Obsessive compulsive behaviour; Olanzapine; Tics

Indexed keywords

CLOTIAPINE; HALOPERIDOL; OLANZAPINE; PAROXETINE; PIMOZIDE; PIPAMPERONE; PROPRANOLOL; RISPERIDONE; SERTRALINE;

ADULT; ARTICLE; BODY WEIGHT DISORDER; CASE REPORT; COMORBIDITY; DISEASE SEVERITY; DROWSINESS; DRUG EFFICACY; DRUG USE; GILLES DE LA TOURETTE SYNDROME; HOSPITAL ADMISSION; HUMAN; MALE; MEDICAL LITERATURE; MEDICAL RESEARCH; OBSESSIVE COMPULSIVE DISORDER; RATING SCALE; TIC; WEIGHT GAIN;

EID: 31744435647     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington DC: American Psychiatric Association, 2000.
2. Baker R. W., Ames D., Umbright D. S. S, Chengappa K. N., Schooler N. R. Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo. J Clin Psychiatry, 1996, 17: 115-119.
3. Bengi Semerci Z. Olanzapine in Tourette's disorder. J Am Acad Child Adolesc Psychiatry, 2000, 39: 140.
4. Bhadrinath B. R. Olanzapine in Tourette syndrome. Br J Psychiatry, 1998, 172: 366.
5. Bogetto F., Bellino S., Vaschetto P., Ziero S. Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12- week open trial. Psychiatry Res, 2000, 96: 91-98.
6. Bogan A. M., Koran L. M., Chuong H. W., Vapnik T., Bystritsky A. Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: an open-label study. J Clin Psychiatry, 2005, 66: 73-79.
7. Bruggeman R., van der Linden C., Buitelaar J. K., Gericke G. S., Hawkridge S. M. et al. Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study. J Clin Psychiatry, 2001, 62: 50-56.
8. Bruun R. D., Budman C. L. Risperidone as a treatment for Tourette's syndrome. J Clin Psychiatry, 1996, 57: 29-31.
9. Budman C. L., Gayer A. G., Lesser M., Shi Q., Bruun R. D. An open-label study of the treatment efficacy of olanzapine for Tourette's Disorder. J Clin Psychiatry, 2001, 62: 290-294.
10. Bystritsky A., Ackerman D. L., Rosen R. M. Augmentation of SSRI response in refractory OCD using adjunctive olanzapine: a placebo controlled trial. Fifth International Obsessive Compulsive Disorder Conference, Sardina, Italy, 2001.
11. Carey P. D., Vythilingum B., Seedat S., Muller J. E., van Ameringen M., Stein D. J. Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study. BMC Psychiatry, 2005, 24: 5.
12. Crocq M. A., Leclercq Ph., Guillon M. S., Bailey P. E. Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment. Eur Psychiatry, 2002, 17: 296-297;
13. D'Amico G., Cedro C., Muscatello M. R., Pandolfo G., Di Rosa A. E. et al. Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry, 2003, 27, 619-623.
14. Denys D., de Geus F., van Megen H. J., Westenberg H. G. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obssessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry, 2004, 65: 1040-1048.
15. Dion Y., Annable L., Sandor P., Chouinard G. Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial. J Clin Psychopharmacol, 2002, 22: 31-39.
16. Fountoulakis K. N., Iacovides A., St Kaprinis G. Successful treatment of Tourette's disorder with amisulpride. Ann Pharmacother 2004, 38: 901.
17. Francobandiera G. Olanzapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder: an open-label study. Can J Psychiatry, 2001, 46 356-358.
18. Gilbert D. L., Batterson J. R., Sethuraman G., Sallee F. R. Tic reduction with risperidone versus pimozide in a randomized, double-blind, cross-over trial. J Am Acad Child Adolesc Psychiatry, 2004, 43: 206-214.
19. Goodman W. K., Price L. H., Rasmussen S. A., Mazure C., Fleischmann R. L., et al. The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry, 1989, 46: 1006-1011.
20. Goodman W. K., Price L. H., Rasmussen S. A., Mazure C., Delgado P. et al. The Yale-Brown Obsessive Compulsive Scale, II: validity. Arch Gen Psychiatry, 1989, 46: 1012-1016.
21. Hollander E., Bienstock C. A., Koran L. M., Pallanti S., Marazziti D. et al. Refractory obsessive-compulsive disorder: state-of-the-art treatment. J Clin Psychiatry, 2002, 63(S6): 20-29.
22. Hollander E., Baldini Rossi N., Sood E., Pallanti S. Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. Int J Neuropsychopharmacol, 2003, 6: 397-401.
23. Jankovic J. Tourette's syndrome. N Engl J Med, 2001, 345: 1184-1192.
24. Jiménez-Jiménez F. J., Garcia-Ruiz P. J. Pharmacological options for the treatment of Tourette's Disorder. Drugs, 2001, 61: 2207-2220.
25. Karam-Hage M., Ghaziuddin N. Olanzapine in Tourette's disorder. J Am Acad Child Adolesc Psychiatry, 2000, 39: 139.
26. Koran L. M., Ringold A. L., Elliot M. A. Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry, 2000, 61: 514-517.
27. Krishnamoorsthy J., King B. H. Open-label olanzapine treatment in five preadolescent children. J Child Adolesc Psychopharmacol 1998, 8: 107-113.
28. Kurlan R. Tourette's syndrome: are stimulants safe ? Curr Neurol Neurosci Rep, 2003, 3: 285-288.
29. Leckman J. F., Riddle M. A., Hardin M. T., Ort S. I., Swartz K. L., et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry, 1989, 28: 566-573.
30. Leckman J. F. Tourette's syndrome. The Lancet, 2002, 360: 1577-1586.
31. Li X., May R. S., Tolbert L. C., Jackson W. T., Flournoy J. M. et al. Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: a cross-over study. J Clin Psychiatry 2005, 66: 736-743.
32. Lieberman J. A., Tollefson G., Tohen M., Green A.I., Gur R. E., et al. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized blind trial of olanzapine versus haloperidol. Am J Psychiatry, 2003, 160: 1396-1404.
33. Lombroso P. J., Scahill J., King R. A., Lynch K. A., Chappell P. B., et al. Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report. J Am Acad Child Adolesc Psychiatry, 1995, 34: 1147-1152.
34. Marazziti D, Pfanner C., Dell'Osso B., Ciaparrelli A., Presta S. et al. Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study. J Psychopharmacol, 2005, 19: 392-394.
35. McDougle C. J., Epperson C. N., Pelton G. H., Wayslink S. Price L. H. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder. Arch Gen Psychiatry, 2000, 57: 794-801.
36. Meisel A., Winter C., Zschenderlein R., Arnold G. Tourette syndrome: efficient treatment with ziprasidone and normalization of body weight in a patient with excessive weight gain under tiapride. Mov Disord, 2004, 19: 991-992.
37. Miguel E. C., Shavitt R. G., Ferrã Y. A., Brottpo S. A., Diniz J. B. How to treat OCD in patients with Tourette syndrome. J Psychosom Res, 2003, 55: 49-57.
38. Mukkades N. M., Abali O. Quetiapine treatment of children and adolescents with Tourette's disorder. J Child Adolesc Psychopharmacol, 2003, 13: 295-299.
39. Onofroj M., Paci C., D'Andreamatteo G., Toma L. Olanzapine in severe Gilles de la Tourette syndrome: a 52-week double-blind cross-over study vs. low-dose pimozide. J Neurol, 2000, 247: 443-446.
40. Párraga H. C., Woodward R. L. Quetiapine for Tourette's syndrome. J Am Acad Child Adolesc Psychiatry, 2001, 40: 389-391.
41. Párraga H. C., Párraga M. I., Woodward R. L., Fenning P. A. Quetiapine treatment of children with Tourette's syndrome: report of two cases. J Child Adolesc Psychopharmacol, 2001, 11: 187-191.
42. Robertson M. M., Schnieden V., Lees A. J. Management of Gilles de la Tourette syndrome using sulpiride. Clin Neuropharmacol, 1990, 13: 229-235.
43. Robertson M. M. Tourette syndrome, associated conditions and the complexities of treatment. Brain, 2000, 123: 425-462.
44. Robertson M. M. Diagnosing Tourette syndrome. Is it a common disorder? J Psychosom Res, 2003, 55: 3-6.
45. Sallee F. R., Kurlan R., Goetz C. G., Singer H., Scahill L., et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry, 2000, 39: 292-299.
46. Sandor P. Pharmacological management of tics in patients with TS. J Psychosom Res, 2003, 55: 41-48.
47. Sareen J., Kirschner A., Lander M., Kjernisted K. D., Eleef M. K., et al. Do antipsychotics ameliorate or exacerbate obsessive compulsive disorder symptoms ? A systematic review. J Affect Disord, 2004, 82: 167-174.
48. Sasson Y, Amiaz R., Nakash N. Olanzapine treatment for schizophrenia patients with refractory OCD: an open-label case series. Fifth International Obsessive Compulsive Disorder Conference, Sardinia, Italy, 2001.
49. Scahill L., Leckman J. F., Shultz R. T., Katsovich L, Peterson B. S. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology, 2003, 60: 1130-1135.
50. Schmider J., Hoff P. Clozapine in Touretteéss syndrome. J Clin Psychopharmacol, 1998, 18: 88-89.
51. Shapira N. A., Ward H. E., Mandoki M., Murphy T. K., Yang M. C., Blier P., et al. A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder. Biol Psychiatry, 2004, 550: 553-555.
52. Shulman L. M., Singer C., Weiner W. J. Risperidone in Gilles de la Tourette syndrome. Neurology, 1995, 45: 1419.
53. Stamenkovic M., Schindler S., Ashauer H., De Zwaan M., Willinger U., et al. Effective open-label treatment of Tourette's disorder with olanzapine. Int Clin Psychopharmacol, 2000, 15: 23-28.
54. Stephens R. J., Bassel C., Sandor P. Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome - a pilot study. 2004, 14: 255-266.
55. Taracena L. M., Rada M. F. Olanzapine in Tourette's syndrome: a report of three cases. (Spanish) Actas Esp Psiquiatr, 2002, 30: 29-132.
56. The Tourette Syndrome Classification Study Group. Definitions and classification of tic disorders. Arch Neurol, 1993, 50: 1013-1016.
57. Tohen M., Chengappa K. N., Suppes T., Baker R. W., Zarate C. A., et al. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Br J Psychiatry, 2004, 184: 337-345.
58. Trillet M., Moreau T., Dalery J., De Villard R., Aimard G. Treatment of Gilles de la Tourette's disease with amisulpride (French) Presse Med, 2001, 3: 175.
59. Van der Linden C., Bruggeman R., van Woerkom T. C. Serotonin-dopamine antagonist and Gilles de la Tourette's syndrome: an open pilot dose-titration study with risperidone. Mov Disord 1994, 9: 687-688.
60. Weiss E. L., Potenza M. N., McDougle C. J., Epperson C. N. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series. J Clin Psychiatry 1999, 60: 524-527